Adage Capital Partners’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-60,000
| Closed | -$1.9M | – | 909 |
|
|
2023
Q3 | $1.9M | Hold |
60,000
| – | – | ﹤0.01% | 738 |
|
|
2023
Q2 | $2.45M | Sell |
60,000
-3,000
| -5% | -$122K | 0.01% | 730 |
|
|
2023
Q1 | $2.35M | Sell |
63,000
-200,000
| -76% | -$7.45M | 0.01% | 757 |
|
|
2022
Q4 | $9.18M | Sell |
263,000
-62,000
| -19% | -$2.16M | 0.02% | 657 |
|
|
2022
Q3 | $18.2M | Buy |
325,000
+149,022
| +85% | +$8.34M | 0.05% | 438 |
|
|
2022
Q2 | $9.11M | Buy |
175,978
+5,000
| +3% | +$259K | 0.02% | 693 |
|
|
2022
Q1 | $12.4M | Sell |
170,978
-546,500
| -76% | -$39.7M | 0.02% | 633 |
|
|
2021
Q4 | $84.8M | Hold |
717,478
| – | – | 0.15% | 147 |
|
|
2021
Q3 | $96.3M | Buy |
717,478
+254,500
| +55% | +$34.1M | 0.19% | 113 |
|
|
2021
Q2 | $75M | Buy |
+462,978
| New | +$75M | 0.15% | 146 |
|